Fertility preservation in pediatric central nervous system tumors: A report from the Children's Oncology Group

Author:

Felker James12ORCID,Bjornard Kari34ORCID,Close Allison5ORCID,Chavez Josuah6,Chow Eric J.7,Meacham Lillian R.8,Burns Karen9ORCID

Affiliation:

1. Division of Hematology/Oncology Department of Pediatrics University of Pittsburgh School of Medicine Pittsburgh Pennsylvania USA

2. UPMC Children's Hospital of Pittsburgh Pittsburgh Pennsylvania USA

3. Division of Hematology/Oncology Department of Pediatrics Indiana University School of Medicine Indianapolis Indiana USA

4. Riley Hospital for Children at Indiana University Health Indianapolis Indiana USA

5. Division of Hematology/Oncology Helen DeVos Children's Hospital, Michigan State University College of Human Medicine Grand Rapids Michigan USA

6. Division of Hematology/Oncology Helen DeVos Children's Hospital Grand Rapids Michigan USA

7. Fred Hutchinson Cancer Center Seattle Children's Hospital Seattle Washington USA

8. Aflac Cancer and Blood Disorders Center Children's Healthcare of Atlanta Pediatric Hematology/Oncology/BMT Emory University Atlanta Atlanta Georgia USA

9. Department of Pediatrics Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, University of Cincinnati School of Medicine Cincinnati Ohio USA

Abstract

AbstractThe Oncofertility Consortium Pediatric Initiative Network has published recommendations about the risks of infertility due to gonadotoxic therapy. We abstracted gonadotoxic therapies from central nervous system (CNS) Children's Oncology Group (COG) protocols between 2000 and 2022. We assigned them as unknown, minimal, significant, or high levels of increased risk for gonadal dysfunction/infertility. Seven of 11 CNS protocols placed patients at a high level of risk in at least one treatment arm. Males (7/11) were most commonly at a high level of risk, followed by pubertal females (6/11) and prepubertal females (5/11), highlighting the importance of pre‐treatment counseling regarding fertility preservation interventions in this population.

Funder

National Cancer Institute

National Institutes of Health

St. Baldrick's Foundation

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3